Cannabis and Cannabinoids
November 18, 2019 (Issue: 1585)
Cannabis (marijuana) contains more than 60
pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
are the best known. THC is the main psychoactive
constituent of cannabis. CBD, unlike THC, does not
produce...more
- S Patel et al. What we do (and don't) know about the health effects of cannabis and whether marijuana is medicine. Ann Intern Med 2017; 166:747.
- National Academies of Sciences, Engineering, and Medicine 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. Available at: http://bit.ly/34I1pkm. Accessed November 7, 2019.
- National Conference of State Legislatures. State medical marijuana laws. Available at: http://bit.ly/2NOJTnY. Accessed November 7, 2019.
- A Mead. Legal and regulatory issues governing cannabis and cannabis-derived products in the United States. Frontiers in Plant Science 2019; 10:1.
- HJ VanDolah et al. Clinician's guide to cannabidiol and hemp oils. Mayo Clin Proc 2019; 94:1840.
- MO Bonn-Miller et al. Labeling accuracy of cannabidiol extracts sold online. JAMA 2017; 318:1708.
- LM Dryburgh et al. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. Br J Clin Pharmacol 2018; 84:2468.
- PJ Hesketh et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2017; 35: 3240.
- G Wilkie et al. Medical marijuana use in oncology: a review. JAMA Oncol 2016; 2:670.
- PF Whiting et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313:2456.
- MH Andreae et al. Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis. J Pain 2015; 16: 1221.
- SM Nugent et al. The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. Ann Intern Med 2017; 167:319.
- A Blake et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med 2017; 6(Suppl 2):S215.
- FDA Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. August 31, 2016. Available at: www.fda.gov. Accessed November 7, 2019.
- M O'Connell et al. Medical cannabis: effects on opioid and benzodiazepine requirements for pain control. Ann Pharmacother 2019; 53:1081.
- BS Koppel et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2014; 82:1556.
- S Nielsen et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep 2018; 18:8.
- A Feinstein et al. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain 2019; 142:2800.
- Cannabidiol (Epidiolex) for epilepsy. Med Lett Drugs Ther 2018; 60:182.
- O Devinsky et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 2016; 15:270.
- X Sun et al. Marijuana for glaucoma: a recipe for disaster or treatment? Yale J Biol Med 2015; 88:265.
- N Black et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry 2019 October 28 (epub).
- TS Kafil et al. Cannabis for the treatment of Crohn's disease. Cochrane Database Syst Rev. 2018; 11:CD012853.
- ND Volkow et al. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219.
- ST Wilkinson et al. Marijuana legalization: impact on physicians and public health. Annu Rev Med 2016; 67:453.
- JR Richards et al. Unintentional cannabis ingestion in children: a systematic review. J Pediatr 2017; 190:142.
- FDA. Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products. August 30, 2019. Available at: http://bit.ly/2pUxEOy. Accessed November 7, 2019.
- SR Baldassarri et al. Vaping—seeking clarity in a time of uncertainty. JAMA 2019 November 7 (epub).
- SA Ryan et al. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics 2018; 142:e20181889.
- The American College of Obstetricians and Gynecologists. Committee Opinion Summary No. 722: Marijuana use during pregnancy and lactation. Obstet Gynecol 2017; 130:931.
- FDA. What you should know about using cannabis, including CBD, when pregnant or breastfeeding. Available at: http://bit.ly/32pRnDg. Accessed November 7, 2019.
- RL Hartman et al. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem 2015; 61:850.
- Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2019 September 20 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
- CDC. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Available at: http://bit.ly/2qoQo9i. Accessed November 18, 2019.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
